We showed that SARS-CoV-2-encoded miRNAs can target the insulin-signaling pathway (Figure 7A, Supplementary Figure 1), and aberration of this pathway might overcomplicate the whole disease condition for COVID-19 patients with existing diabetic problems (Shimizu et al., 1980; del Campo et al., 2012). This evidence concerns the gene INS and COVID-19.